Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs Kina

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Kina a 75. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

Kina

#129 · Grade C+ · Fair Price

Est. first month

From $179/mo (starting dose, plus a separate fee, compounded)

Save ~87% vs brand-name
Get this deal Full Kina review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 75 an est. $99/mo first month, with no teaser step-up baked in. Kina isn't out of it: Shoppers who want women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsKina
Value Score90 (A)75 (C+)
Est. first month$99/moFrom $179/mo (starting dose, plus a separate fee, compounded)
Save vs brand-name~93%~87%
Semaglutide$99/moFrom $179/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$145/moFrom $179/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
76
Alan Meds: 95. Kina: 76.
85
No Teaser-Rate Bait
64
Alan Meds: 85. Kina: 64.
98
Nationwide Availability
45
Alan Meds: 98. Kina: 45.
94
Both Molecules
92
Alan Meds: 94. Kina: 92.
82
Easy Cancellation
95
Alan Meds: 82. Kina: 95.
72
Reputation
80
Alan Meds: 72. Kina: 80.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

Kina

Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Why it's a deal

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

The fine print

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published
Get the Alan Meds deal Get the Kina deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Kina.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.